Business
from24/7 Wall St.
2 days agoGuggenheim Trims Amgen Price Target to $340: Is the Biotech Giant Losing Its Edge?
Guggenheim lowered Amgen's price target to $340, reflecting cautious sentiment amid biosimilar competition and a modest model update after Q1 2026 earnings.